HYOSCINE HYDROBROMIDE

Important: Therapy notes

MHRA advice: Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects, including hyperthermia (July 2023) (www.gov.uk).

  • For the use of hyoscine in palliative care refer to Antiemetics used in palliative care.
  • Sedation can be a problematic side-effect if driving or operating machinery is required.

Important: Formulation and dosage details

Formulation:

Chewable tabletsOTC 150 micrograms, 300 micrograms

Dosage:

Motion sickness, by mouth, 150 to 300 micrograms up to 30 minutes before start of journey, repeat every 6 hours as required, up to 3 doses in 24 hours. 

Important: Formulation and dosage details

Formulation:

Transdermal patchesOTC 1mg/72 hours

Dosage:

Motion sickness, the patch may be used as an alternative to tablets, 1 patch placed behind the ear 5 to 6 hours before journey may remain in place for up to 72 hours. Place replacement patch behind other ear.

Important: Formulation and dosage details

Formulation:

Injection 400 micrograms/1mL

Editorial Information

Document Id: F087